Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129715) titled 'Sclerosing epithelioid fibrosarcoma with initial presentation as pulmonary masses: clinicopathological characteristics and diagnostic challenges' on Aug. 8.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Affiliated Hospital of Army Medical University
Condition:
sclerosing epithelioid fibrosarcoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-15
Target Sample Size: Patients with sclerosing epithelioid fibrosarcoma:4;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=336710
Published...